65 related articles for article (PubMed ID: 1370180)
1. G-CSF for fever and neutropenia induced by chemotherapy.
Hamm JT
N Engl J Med; 1992 Jan; 326(4):269; author reply 270. PubMed ID: 1370180
[No Abstract] [Full Text] [Related]
2. [Small cell lung cancer: value of G-CSF].
Trillet V
Pathol Biol (Paris); 1993 Jan; 41(1):46. PubMed ID: 7686284
[No Abstract] [Full Text] [Related]
3. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
[TBL] [Abstract][Full Text] [Related]
4. G-CSF reduces incidence of chemotherapy-associated infections.
Oncology (Williston Park); 1990 Aug; 4(8):12. PubMed ID: 1698430
[No Abstract] [Full Text] [Related]
5. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
6. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
7. The use of GM-CSF as adjunctive therapy in small cell lung cancer. Presentation of the interim analysis of a large phase II trial.
Pujol JL; Tabah I; Michel FB
Pathol Biol (Paris); 1992 Nov; 39(9):960. PubMed ID: 1311449
[No Abstract] [Full Text] [Related]
8. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
9. [Cytokines in cancer chemotherapy: present state and problems in use of G- and GM-CSF for solid tumors in Japan].
Ogawara M
Gan To Kagaku Ryoho; 1998 Jan; 25(2):164-70. PubMed ID: 9474924
[TBL] [Abstract][Full Text] [Related]
10. Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy.
Timmer-Bonte JN; Adang EM; Termeer E; Severens JL; Tjan-Heijnen VC
J Clin Oncol; 2008 Jan; 26(2):290-6. PubMed ID: 18182670
[TBL] [Abstract][Full Text] [Related]
11. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
Ohnoshi T; Ueoka H; Kodani T; Kamei H; Kimura I
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
[TBL] [Abstract][Full Text] [Related]
12. G-CSF for fever and neutropenia induced by chemotherapy.
Auchter RM
N Engl J Med; 1992 Jan; 326(4):269-70. PubMed ID: 1370183
[No Abstract] [Full Text] [Related]
13. [Role of hematopoietic growth factors in bronchial cancerology].
Lemarié E; Milleron B
Rev Mal Respir; 1995; 12(5):429-34. PubMed ID: 8560073
[TBL] [Abstract][Full Text] [Related]
14. Colony-stimulating factor therapy and febrile neutropenia induced by chemotherapy: need for economical studies.
Urban T; Lebeau B
Eur Respir J; 1999 Jun; 13(6):1228-9. PubMed ID: 10445594
[No Abstract] [Full Text] [Related]
15. Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases.
Kavgaci H; Ozdemir F; Aydin F; Yavuz A; Yavuz M
J Exp Clin Cancer Res; 2002 Dec; 21(4):475-9. PubMed ID: 12636092
[TBL] [Abstract][Full Text] [Related]
16. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
Crawford J; O'Rourke MA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
[TBL] [Abstract][Full Text] [Related]
18. [Dose intensity of chemotherapy in small-cell lung carcinoma. Review of comparative studies].
Sanz Rubiales A; del Valle Rivero ML; Garavís Vicente M; Rey Castro P; López-Lara Martín F
An Med Interna; 2000 Jul; 17(7):378-85. PubMed ID: 10981338
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.
Bronchud M; Scarffe JH; Thatcher N; Crowther D; Souza LM; Alton NK; Testa NG; Dexter TM
Behring Inst Mitt; 1988 Aug; (83):327-9. PubMed ID: 2467655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]